{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:20:13Z","timestamp":1789852813763,"version":"4.0.1"},"reference-count":35,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.3892\/mmr.2017.7678","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T07:23:29Z","timestamp":1506669809000},"page":"8164-8170","source":"Crossref","is-referenced-by-count":34,"title":["Defective insulin signaling and the protective effects of dimethyldiguanide during follicular development in the ovaries of polycystic ovary syndrome"],"prefix":"10.3892","volume":"16","author":[{"given":"Fan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaizhuan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,9,29]]},"reference":[{"key":"key20180108005730_b1-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1385\/ENDO:30:1:3","article-title":"Diagnostic criteria for polycystic ovarian syndrome","volume":"30","author":"Broekmans","year":"2006","journal-title":"Endocrine"},{"key":"key20180108005730_b2-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/01.ogx.0000197817.93201.04","article-title":"Polycystic ovary syndrome and its differential diagnosis","volume":"61","author":"Lane","year":"2006","journal-title":"Obstet Gynecol Surv"},{"key":"key20180108005730_b3-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/09513590.2011.583955","article-title":"PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: An update","volume":"28","author":"Makker","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"key20180108005730_b4-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/jc.2014-2419","article-title":"Up-regulated expression of WNT5a increases inflammation and oxidative stress via PI3K\/AKT\/NF-\u03baB signaling in the granulosa cells of PCOS patients","volume":"100","author":"Zhao","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108005730_b5-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/1933719116667606","article-title":"Role of the PI3K-Akt signaling pathway in the pathogenesis of polycystic ovary syndrome","volume":"24","author":"Li","year":"2017","journal-title":"Reprod Sci"},{"key":"key20180108005730_b6-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1210\/jc.2002-021131","article-title":"Polycystic ovary syndrome, insulin resistance and molecular defects of insulin signaling","volume":"87","author":"Azziz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108005730_b7-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.fertnstert.2006.04.011","article-title":"Insulin resistance in women with polycystic ovary syndrome","volume":"86","author":"Dunaif","year":"2006","journal-title":"Fertil Steril"},{"key":"key20180108005730_b8-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1515\/CCLM.2003.173","article-title":"Insulin resistant states and insulin signaling","volume":"41","author":"Vollenweider","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"key20180108005730_b9-mmr-16-06-8164","first-page":"141","article-title":"Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women","volume":"37","author":"Skrgati\u0107","year":"2013","journal-title":"Coll Antropol"},{"key":"key20180108005730_b10-mmr-16-06-8164","first-page":"S1291","article-title":"Molecular defects of insulin action in the polycystic ovary syndrome: Possible tissue specificity","volume":"13","author":"Ciaraldi","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key20180108005730_b11-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jsbmb.2008.03.014","article-title":"Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS)","volume":"109","author":"Diamanti-Kandarakis","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"key20180108005730_b12-mmr-16-06-8164","first-page":"3110","article-title":"Selective insulin resistance in the polycystic ovary syndrome","volume":"84","author":"Book","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108005730_b13-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0015-0282(03)01007-0","article-title":"Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome","volume":"80","author":"Wu","year":"2003","journal-title":"Fertil Steril"},{"key":"key20180108005730_b14-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/rp.56.1.295","article-title":"Insulin resistance in polycystic ovary syndrome: Progress and paradoxes","volume":"56","author":"Venkatesan","year":"2001","journal-title":"Recent Prog Horm Res"},{"key":"key20180108005730_b15-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1055\/s-0034-1372578","article-title":"Phosphatidylinositide-3 kinase: A newer molecular target in metabolic and hormonal pathway of polycystic ovary syndrome","volume":"122","author":"Shah","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"key20180108005730_b16-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0962-8924(01)02207-3","article-title":"Insulin signaling pathways in time and space","volume":"12","author":"Saltiel","year":"2002","journal-title":"Trends Cell Biol"},{"key":"key20180108005730_b17-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.ecl.2016.06.008","article-title":"Metformin: From research to clinical practice","volume":"45","author":"Tan","year":"2016","journal-title":"Endocrinol Metab Clin North Am"},{"key":"key20180108005730_b18-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2217\/WHE.10.43","article-title":"Use of metformin in the treatment of polycystic ovary syndrome","volume":"6","author":"Genazzani","year":"2010","journal-title":"Womens Health (Lond)"},{"key":"key20180108005730_b19-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/09513590.2016.1236078","article-title":"Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS)","volume":"33","author":"Fruzzetti","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"key20180108005730_b20-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"E120","DOI":"10.25011\/cim.v39i4.27091","article-title":"Effect of metformin treatment during pregnancy on women with PCOS: A systematic review and meta-analysis","volume":"39","author":"Tan","year":"2016","journal-title":"Clin Invest Med"},{"key":"key20180108005730_b21-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/09513590500476164","article-title":"Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome","volume":"22","author":"Genazzani","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"key20180108005730_b22-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/09513590701214398","article-title":"Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia","volume":"23","author":"Genazzani","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"key20180108005730_b23-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10735-015-9609-4","article-title":"Expression and clinical significance of the HIF-1a\/ET-2 signaling pathway during the development and treatment of polycystic ovary syndrome","volume":"46","author":"Wang","year":"2015","journal-title":"J Mol Histol"},{"key":"key20180108005730_b24-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2008-0030","article-title":"Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: A comprehensive review","volume":"30","author":"Palomba","year":"2009","journal-title":"Endocr Rev"},{"key":"key20180108005730_b25-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7150\/jca.8009","article-title":"Combination of diane-35 and metformin to treat early endometrial carcinoma in PCOS women with insulin resistance","volume":"5","author":"Li","year":"2014","journal-title":"J Cancer"},{"key":"key20180108005730_b26-mmr-16-06-8164","first-page":"119","article-title":"The IRS-signaling system: A network of docking proteins that mediate insulin and cytokine action","volume":"53","author":"White","year":"1998","journal-title":"Recent Prog Horm Res"},{"key":"key20180108005730_b27-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/36116","article-title":"Disruption of IRS-2 causes type 2 diabetes in mice","volume":"391","author":"Withers","year":"1998","journal-title":"Nature"},{"key":"key20180108005730_b28-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.2337\/diabetes.49.11.1880","article-title":"Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia","volume":"49","author":"Kubota","year":"2000","journal-title":"Diabetes"},{"key":"key20180108005730_b29-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/35030105","article-title":"IRS-2 pathways integrate female reproduction and energy homeostasis","volume":"407","author":"Burks","year":"2000","journal-title":"Nature"},{"key":"key20180108005730_b30-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cca.2006.07.005","article-title":"Molecular mechanisms of insulin resistance and associated diseases","volume":"375","author":"Mlinar","year":"2007","journal-title":"Clin Chim Acta"},{"key":"key20180108005730_b31-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1042\/bj3330471","article-title":"Phosphoinositide 3-kinase: The key switch mechanism in insulin signalling","volume":"333","author":"Shepherd","year":"1998","journal-title":"Biochem J"},{"key":"key20180108005730_b32-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11655-015-2147-9","article-title":"Potent therapeutic effects of shouwu jiangqi decoction on polycystic ovary syndrome with insulin resistance in rats","volume":"22","author":"Wang","year":"2016","journal-title":"Chin J Integr Med"},{"key":"key20180108005730_b33-mmr-16-06-8164","first-page":"178","article-title":"PDK1: A signaling hub for cell migration and tumor invasion","volume":"1856","author":"Gagliardi","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"key20180108005730_b34-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4331\/wjbc.v1.i8.239","article-title":"Multiple implications of 3-phosphoinositide-dependent protein kinase 1 in human cancer","volume":"1","author":"Li","year":"2010","journal-title":"World J Biol Chem"},{"key":"key20180108005730_b35-mmr-16-06-8164","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/mrd.22333","article-title":"Mechanistic target of rapamycin (MTOR) signaling during ovulation in mice","volume":"81","author":"Siddappa","year":"2014","journal-title":"Mol Reprod Dev"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T01:58:13Z","timestamp":1515376693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.7678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,29]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,9,29]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.3892\/mmr.2017.7678"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.7678","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,29]]}}}